Phenotype / cell stem origin M1, M2, and M4 ANLL; therapy related ANLL; MDS evolving towards ANLL; stem cell immunophenotype (DR+, CD34+, and CD15, 33 and/or 13 positive); trilineage dysplasia may be present. To be noted that M1 and M2 subtypes of ANLL have rarely been found associated with the classical MLL rearrangements. Epidemiology Frequency: 1% of ANLL and MDS as well; balanced sex ratio; found in adults; med age: 60 yrs. Prognosis Short CR; poor prognosis.
Clinics and pathology

Disease
Myeloid lineage: (ANLL, MDS) Phenotype / cell stem origin M1, M2, and M4 ANLL; therapy related ANLL; MDS evolving towards ANLL; stem cell immunophenotype (DR+, CD34+, and CD15, 33 and/or 13 positive); trilineage dysplasia may be present. To be noted that M1 and M2 subtypes of ANLL have rarely been found associated with the classical MLL rearrangements. Epidemiology Frequency: 1% of ANLL and MDS as well; balanced sex ratio; found in adults; med age: 60 yrs. Prognosis Short CR; poor prognosis.
Cytogenetics
Cytogenetics, morphological
+11
Cytogenetics, molecular
Partial tandem duplication (in situ) of MLL gene located in 11q23.
Probes
Oncor, Inc.
Additional anomalies
None (by that very fact).
Genes involved and Proteins
MLL
Location: 11q23 DNA / RNA 21 exons, spanning over 100 kb; 13-15 kb mRNA. Protein 431 kDa; contains two DNA binding motifs (a AT hook, and Zinc fingers), a DNA methyl transferase motif, a bromodomain; wide expression; nuclear localisation; transcriptional regulatory factor.
Results of the chromosomal anomaly
Hybrid gene
Description Exons 1 to 6 or 8 fused to a nearly entire MLL gene, starting at exon 2 (i.e. the duplicated segment is E2 to E6 or 8).
Fusion protein
Description AT hook and DNA methyltransferase from MLL in Nterm fused to a quite entire MLL in C-term. Expression localisation Nuclear localisation. Oncogenesis Probable altered transcriptional regulation.
To be noted
Such a tandem duplication of MLL may also be found in cases with a normal karyotype.
